Questcor Pharmaceuticals (QCOR) Inactive 10-Q2011 Q1 Quarterly report

Filed: 27 Apr 11, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Good

New words: anther, APIC, bearing, capacity, commonly, component, concept, corporate, correlated, currency, debate, decline, deposit, depositor, diabetic, direct, director, disposal, dispute, diversification, environmental, exposed, extent, foreign, foreseeable, fullest, headcount, impose, incremental, indemnification, indemnify, inflow, infrastructure, institution, intact, invoicing, IV, large, leasehold, liquid, liquidity, litigation, mandated, methodology, nephrology, objective, outflow, permissible, Phase, preserve, prevailing, pronouncement, proof, proprietary, pursue, pursuing, qualitative, ratio, reliance, repeal, revert, serving, short, simplified, threatened, Topic, translation, trial, unforeseen, write

Removed: accounted, ACTH, actively, adjustment, adrenocorticotropic, ALS, amyotrophic, approving, April, assumed, assumption, attract, audited, benchmark, blood, brain, called, CEO, childhood, classification, clinically, Code, comparable, conjunction, consisting, consulting, decrease, deduction, demonstrated, derive, derived, designation, disinterested, disorder, domestic, dosing, driven, educate, eliminate, ending, entity, epilepsy, exacerbation, examining, exclusivity, exploratory, family, fourth, Gehrig, goal, healthcare, hired, historic, historically, hormone, hospital, identify, incidence, incorporating, incurred, initiated, injury, interim, IRC, issuance, IVAX, June, kidney, labeled, leading, legal, longer, Lou, low, maintenance, making, marketplace, meaningful, member, necessarily, notice, observability, obtained, opinion, orphan, ownership, Plant, population, prepaid, prepared, presentation, production, prohibited, protein, range, read, receipt, reclassification, Recoverability, reduce, relate, renal, replacement, responded, resubmission, retain, royalty, seasonal, seasonality, security, Senior, sheet, shipping, sNDA, strategy, substantial, successfully, sufficient, superior, system, traded, traumatic, unaudited, undiscounted, urine, utilization, variability, Vice, yield

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

QCOR similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION

I, Kristine Engelke, hereby certify pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, that the Quarterly Report of Questcor Pharmaceuticals, Inc. on Form 10-Q for the quarterly period ended March 31, 2011 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q for the period ended March 31, 2011 fairly presents in all material respects the financial condition and results of operations of Questcor Pharmaceuticals, Inc.

Date: April 27, 2011

/s/ Kristine Engelke

Kristine Engelke

Principal Accounting Officer

This certification accompanies the Quarterly Report on Form 10-Q pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 and shall not be deemed filed by Questcor Pharmaceuticals, Inc. for purposes of Section 18 of the Securities Exchange Act of 1934.